A Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCC

Clinical trial NCT07733180 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07733180
Sponsor: BeOne Medicines
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Esophageal Squamous Cell Carcinoma Metastatic Esophageal Squamous Cell Carcinoma

Start date: 2026-08-31
Primary completion: 2028-02-28
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.